Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension.
Yuchi HanPaul R ForfiaAnjali VaidyaJeremy A MazurekMyung H ParkGautam RamaniStephen Y ChanAaron B WaxmanPublished in: Open heart (2018)
NCT01839110 and NCT02829034; Pre-results.